US 10035981
Kidney-specific tumor vaccine directed against kidney tumor antigen G-250
granted A61KA61K2039/53A61K2039/54
Quick answer
US patent 10035981 (Kidney-specific tumor vaccine directed against kidney tumor antigen G-250) held by The Regents of the University of California expires Mon Jul 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Jul 31 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K2039/53, A61K2039/54, A61K2039/55516, A61K2039/55522